A better way to study Parkinson’s disease in the lab could lead to earlier diagnosis

A study published in Progress in Neurobiology and led by researchers at the University of Arizona College of Medicine, Tucson, has developed an improved method to study Parkinson’s disease in the lab. Along the way, researchers also uncovered clues that may help scientists figure out how to detect Parkinson’s earlier and point the way toward better treatments.

Microbubble gene therapy may protect against heart disease

Gene therapy has great promise for treating genetic diseases, and even for more common diseases such as atherosclerosis (hardening of the arteries). Over the past decade, the gene-editing technology CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)—a family of DNA sequences found in the genomes of certain bacteria—has allowed scientists to fix individual errors in the genetic code that cause disease.